Importantly, inhibition of the Akt pathway by an Akt inhibitor blocked the stimulation of NSCLC cell metastasis and tumorigenicity that was otherwise induced by downregulation of pro-SFTPB expression. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.